CD19-CD22 CAR T cell infusion: Clinical Trials

1 trial of CD19-CD22 CAR T cell infusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow CD19-CD22 CAR T cell infusion: new trials by email Literature Review of CD19-CD22 CAR T cell infusion trials Research Report on CD19-CD22 CAR T cell infusion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
Fludarabine, Cyclophosphamide, Mesna - Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia
Phase 1RecruitingSt. Jude Children's Research Hospital302025-04-282026-05-19

Conditions studied

Burkitt Lymphoma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

St. Jude Children's Research Hospital (1)

Countries

United States (1)

Top investigators

Rebecca Epperly, MD (1)